Scalp Hypothermia (Penguin Cold Caps) in Preventing Alopecia in Cancer Patients

Cancer morbidity and mortality are severe public health problems that are increasing day by day. In addition to their benefits of some methods, such as chemotherapy and radiotherapy, which are applied for cancer treatment, there are some side effects and complications, such as skin reactions, hair loss, fatigue, vomiting and loss of appetite. In this article, one of these complications and affecting more than half of the patients who receive cancer treatment alopecia will be mentioned. Alopecia may be temporary or permanent, but it has been stated by health professionals that this problem is often ignored. Alopecia affects body image in individuals, increases the level of stress, causes anxiety and depression and even individuals are exposed to stigma. The emergence of these problems in the patient also affects the quality of life negatively. To prevent alopecia, which can be seen especially due to chemotherapy, the process of cooling the scalp has started to be applied about 50 years ago and the materials used thanks to the changing materials science have been developed. In this study, the efficacy of scalp hypothermia (Penguin Cold Caps) in the prevention of alopecia, which is frequently seen due to chemotherapy, has been evaluated and it is aimed to investigate the relevant studies.

PDF

___

1. World Health Organization database: Health Systems Strengthening Glossary retrieved. Available at: http:// www.who.int/healthsystems/hss_glossary/en/index5. html Accessed Feb 3, 2020.
2. Gonzalez VJ, McMillan S, Pedro E, Tirado-Gomez M, Saligan LN. The Health related Quality of Life of Puerto Ricans during Cancer Treatments; A Pilot Study. P R Health Sci J 2018;37(1):46–51.
3. Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin 2015;65(2):87–108.
4. Menon A, Handattu S, Shetty J, Shanmukha Girisha B. Study of Cutaneous Adverse Effects of Cancer Chemotherapy. Clinical Dermatology Review 2018;2(1):19–24.
5. Beard JR, Officer A, de Carvalho IA, Sadana R, Pot AM, Michel JP, et al. The World report on ageing and health: a policy framework for healthy ageing. Lancet 2016;387(10033):2145–54.
6. Clarfield AM. Healthy Life Expectancy Is Expanding. J Am Geriatr Soc 2018;66(1):200–1.
7. Yaghoobzadeh A, Gorgulu O, Yee BL, Wibisono AH, Pahlevan Sharif S, Sharif Nia H, et al. A Model of Aging Perception in Iranian Elders With Effects of Hope, Life Satisfaction, and Socioeconomic Status: A Path Analysis. J Am Psychiatr Nurses Assoc 2018;24(6):522–30.
8. World Health Organization database: Cancer fact sheet retrieved. Available at: http://www.who.int/mediacentre/factsheets/fs297/en/. Accessed Feb 3, 2020.
9. DuGoff EH, Canudas-Romo V, Buttorff C, Leff B, Anderson GF. Multiple Chronic Conditions and Life Expectancy: A Life Table Analysis. Med Care 2014;52(8):688–94.
10. Demmer RT, Barondess JA. On the Communicability of Chronic Diseases. Ann Intern Med 2018;168(1):6970.
11. World Health Organization database: The top 10 causes of death fact sheet retrieved. Available at: http:// www.who.int/mediacentre/factsheets/fs310/en/. Accessed Feb 3, 2020.
12. Kemp BR, Ferraro KF, Morton PM, Mustillo SA. Early Origins of Adult Cancer Risk Among Men and Women: Influence of Childhood Misfortune? J Aging Health 2018;30(1):140–63.
13. World Health Organization Regional Office for Europe database: from data and statistics fact sheet retrieved. www.euro.who.int/en/health.../cancer/data-and-statistics [visited March 25, 2018].
14. National Cancer Institute database: What Is Cancer?. https://www.cancer.gov/about-cancer/.../what-iscancer [visited March 26, 2018].
15. Cancer Research UK database: What is cancer?. Available at: www.cancerresearchuk.org/about-cancer/ what-is-cancer. Accessed Feb 3, 2020.
16. 12.Türkiye Kanser İstatistikleri. http://kanser.gov. tr/Dosya/ca_istatistik/ANA_rapor_2013v01_2.pdf [Erişim Tarihi: 12.02.2018].
17. 13.Türkiye İstatistik Kurumu. Ölüm Nedeni İstatistikleri. Available at: http://www.tuik.gov.tr/PreHaberBultenleri.do?id=24572. Accessed Feb 4, 2020.
18. Fokas E, Rödel C. Targeted agents in GI radiotherapy: Clinical efficacy and side effects. Best Pract Res Clin Gastroenterol 2016;30(4):537–49.
19. Baykara O. Current Modalıtıes In Treatment Of Cancer. Balıkesır Health Sciences Journal 2016;5(3):154–65.
20. Halk Sağlığı Genel Müdürlüğü. Kanser Tedavi Nelerdir? Available at: http://www.kanser.saglik.gov.tr/. Accessed Feb 4, 2020.
21. Ünal O, Kars B. Postmenapozal hormon tedavisi (HT) ve kanser riski. TJOD-Uzmanlık Sonrası Eitim ve Güncel Gelimeler 2004;1:51–7.
22. Na Z, Qiaoyuan Y, Binghan W, Qin Z, Yue C, Xin P, et al. A developed model of cancer patients participation in intravenous chemotherapy safety. Oncotarget 2017;8(50):87598–606.
23. Beusterien K, Grinspan J, Kuchuk I, Mazzarello S, Dent S, Gertler S, et al. Use of conjoint analysis to assess breast cancer patient preferences for chemotherapy side effects. Oncologist 2014;19(2):127–34.
24. Demaria M, O'Leary MN, Chang J, Shao L, Liu S, Alimirah F, et al. Cellular Senescence Promotes Adverse Effects of Chemotherapy and Cancer Relapse. Cancer Discov 2017;7(2):165–76.
25. Pearce A, Haas M, Viney R, Pearson SA, Haywood P, Brown C, et al. Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study. PLoS One 2017;12(10):e0184360.
26. Gurung S, Pandey RA. Perception of Side Effects of Chemotherapy among Cancer Patients in B.P. Koirala Memorial Cancer Hospital Bharatpur. Journal of College of Medical Sciences-Nepal 2015;11(4):14–9.
27. Dua P, Heiland MF, Kracen AC, Deshields TL. Cancerrelated hair loss: a selective review of the alopecia research literature. Psychooncology 2017;26(4):43843.
28. Kim GM, Kim S, Park HS, Kim JY, Nam S, Park S, et al. Chemotherapy-induced irreversible alopecia in early breast cancer patients. Breast Cancer Res Treat 2017;163(3):527–33.
29. Muth CC. Chemotherapy and Hair Loss. JAMA 2017;317(6):656.
30. West HJ. Chemotherapy-Induced Hair Loss (Alopecia). JAMA Oncol 2017;3(8):1147.
31. Hilton S, Hunt K, Emslie C, Salinas M, Ziebland S. Have men been overlooked? A comparison of young men and women's experiences of chemotherapy-induced alopecia. Psychooncology 2008;17(6):577–83.
32. Villasante A C, Herskovitz I, Mauro LM, Jimenez J J. Chemotherapy-Induced Alopecia. J Clin Investigat Dermatol 2014;2(2):1–8.
33. Hesketh PJ, Batchelor D, Golant M, Lyman GH, Rhodes N, Yardley D. Chemotherapy-induced alope cia: psychosocial impact and therapeutic approaches. Support Care Cancer 2004;12(8):543–9.
34. Dąbrowski T. Hair loss as a consequence of cancer chemotherapy – physical methods of prevention. A review of the literature. Contemporary Oncology 2011;2(2):95–101.
35. Trusson D, Pilnick A. The Role of Hair Loss in Cancer Identity: Perceptions of Chemotherapy-Induced Alopecia Among Women Treated for Early-Stage Breast Cancer or Ductal Carcinoma in Situ. Cancer Nurs 2017;40(2):E9–E16.
36. Jayde V, Boughton M, Blomfield P. The experience of chemotherapy-induced alopecia for Australian women with ovarian cancer. Eur J Cancer Care (Engl) 2013;22(4):503–12.
37. Erol O, Can G, Aydıner A. Effects of alopecia on body image and quality of life of Turkish cancer women with or without headscarf. Support Care Cancer 2012;20(10):2349–56.
38. Baati I, Mnif L, Masmoudi J, Allouche C, Damak R, Halwani N, et al. Psychological impact of chemotherapy induced alopecia. European Psychiatry 2010;25(1):869.
39. Choi EK, Kim IR, Chang O, Kang D, Nam SJ, Lee JE, et al. Impact of chemotherapy-induced alopecia distress on body image, psychosocial well-being, and depression in breast cancer patients. Psychooncology 2014;23(10):1103–10.
40. Katikaneni R, Ponnapakkam T, Matsushita O, Sakon J, Gensure R. Treatment and prevention of chemotherapy-induced alopecia with PTH-CBD, a collagen-targeted parathyroid hormone analog, in a non-depilated mouse model. Anticancer Drugs 2014;25(1):30–8.
41. Rubio-Gonzalez B, Juhász M, Fortman J, Mesinkovska NA. Pathogenesis and treatment options for chemotherapy-induced alopecia: a systematic review. Int J Dermatol 2018;57(12):1417–24.
42. Balagula Y, Rosen ST, Lacouture ME. The emergence of supportive oncodermatology: the study of dermatologic adverse events to cancer therapies. J Am Acad Dermatol. 2011;65(3):624–35.
43. Kim IR, Cho J, Choi EK, Kwon IG, Sung YH, Lee JE, et al. Perception, attitudes, preparedness and experience of chemotherapy-induced alopecia among breast cancer patients: a qualitative study. Asian Pac J Cancer Prev 2012;13(4):1383–8.
44. Batchelor D. Hair and cancer chemotherapy: consequences and nursing care--a literature study. Eur J Cancer Care (Engl) 2001;10(3):147–63.
45. Hunt N, McHale S. The psychological impact of alopecia. BMJ 2005;331(7522):951–3.
46. Carelle N, Piotto E, Bellanger A, Germanaud J, T huillier A, Khayat D. Changing patient perceptions of the side effects of cancer chemotherapy. Cancer 2002;95(1):155–63.
47. Komen MM, Smorenburg CH, van den Hurk CJ, Nortier JW. Factors influencing the effectiveness of scalp cooling in the prevention of chemotherapy-induced alopecia. Oncologist 2013;18(7):885–91.
48. Belum VR, de Barros Silva G, Laloni MT, Ciccolini K, Goldfarb SB, Norton L, et al. Cold thermal injury from cold caps used for the prevention of chemotherapy-induced alopecia. Breast Cancer Res Treat 2016;157(2):395–400.
49. Ridderheim M, Bjurberg M, Gustavsson A. Scalp hypothermia to prevent chemotherapy-induced alopecia is effective and safe: a pilot study of a new digitized scalp-cooling system used in 74 patients. Support Care Cancer 2003;11(6):371–7.
50. Nangia J, Wang T, Osborne C, Niravath P, Otte K, Papish S, et al. Effect of a Scalp Cooling Device on Alopecia in Women Undergoing Chemotherapy for Breast Cancer: The SCALP Randomized Clinical Trial. JAMA 2017;317(6):596–605.
51. Shin H, Jo SJ, Kim DH, Kwon O, Myung SK. Efficacy of interventions for prevention of chemotherapy-induced alopecia: a systematic review and meta-analysis. Int J Cancer 2015;136(5):E442–54.
52. van den Hurk CJ, Breed WP, Nortier JW. Short postinfusion scalp cooling time in the prevention of docetaxel-induced alopecia. Support Care Cancer 2012;20(12):3255–60.
53. van den Hurk CJ, Peerbooms M, van de Poll-Franse LV, Nortier JW, Coebergh JW, Breed WP. Scalp cooling for hair preservation and associated characteristics in 1411 chemotherapy patients - results of the Dutch Scalp Cooling Registry. Acta Oncol 2012;51(4):497504.
54. Peck HJ, Mitchell H, Stewart AL. Evaluating the eff icacy of scalp cooling using the Penguin cold cap system to reduce alopecia in patients undergoing chemotherapy for breast cancer. Eur J Oncol Nurs 2000;4(4):246–8.
55. Ekwall EM, Nygren LM, Gustafsson AO, Sorbe BG. Determination of the most effective cooling temperature for the prevention of chemotherapy-induced alopecia. Mol Clin Oncol 2013;1(6):1065–71.
56. van den Hurk CJ, Mols F, Vingerhoets AJ, Breed WP. Impact of alopecia and scalp cooling on the wellbeing of breast cancer patients. Psychooncology 2010;19(7):701–9.
57. Mols F, van den Hurk CJ, Vingerhoets AJ, Breed WP. Scalp cooling to prevent chemotherapy-induced hair loss: practical and clinical considerations. Support Care Cancer 2009;17(2):181–9.
58. Grevelman EG, Breed WP. Prevention of chemotherapy-induced hair loss by scalp cooling. Ann Oncol 2005;16(3):352–8.
59. Rugo HS, Klein P, Melin SA, Hurvitz SA, Melisko ME, Moore A, et al. Association Between Use of a Scalp Cooling Device and Alopecia After Chemotherapy for Breast Cancer. JAMA 2017;317(6):606–14.
60. Rice BA, Ver Hoeve ES, DeLuca AN, Esserman LJ, Rugo HS, Melisko ME. Registry study to assess hair loss prevention with the Penguin Cold Cap in breast cancer patients receiving chemotherapy. Breast Cancer Res Treat 2018;167(1):117–22.
61. Katsimbri P, Bamias A, Pavlidis N. Prevention of chemotherapy-induced alopecia using an effective scalp cooling system. Eur J Cancer 2000;36(6):76671.
62. Kargar M, Sarvestani RS, Khojasteh HN, Heidari MT. Efficacy of penguin cap as scalp cooling system for prevention of alopecia in patients undergoing chemotherapy. J Adv Nurs 2011;67(11):2473–7.
63. Cigler T, Isseroff D, Fiederlein B, Schneider S, Chuang E, Vahdat L, et al. Efficacy of Scalp Cooling in Preventing Chemotherapy-Induced Alopecia in Breast Cancer Patients Receiving Adjuvant Docetaxel and Cyclophosphamide Chemotherapy. Clin Breast Cancer 2015;15(5):332–4.
64. van den Hurk C, Keizer-Heldens P, Raats I, Hoeijmakers K, Mols F. Improving Information Provision on Chemotherapy-Induced Alopecia and Scalp Cooling: A Comprehensive Approach Including A Website and Web-Based Decision Tool. Asia Pac J Oncol Nurs 2019;6(4):336–42.
65. Rugo HS, Melin SA, Voigt J. Scalp cooling with adjuvant/neoadjuvant chemotherapy for breast cancer and the risk of scalp metastases: systematic review and meta-analysis. Breast Cancer Res Treat 2017;163(2):199–205.
66. Kinoshita T, Nakayama T, Fukuma E, Inokuchi M, Ishiguro H, Ogo E, et al. Efficacy of Scalp Cooling in Preventing and Recovering From Chemotherapy-Induced Alopecia in Breast Cancer Patients: The HOPE Study. Front Oncol 2019;9:733.
67. Marks DH, Okhovat JP, Hagigeorges D, Manatis-Lornell AJ, Isakoff SJ, Lacouture ME, et al. The effect of scalp cooling on CIA-related quality of life in breast cancer patients: a systematic review. Breast Cancer Res Treat 2019;175(2):267–76.
68. Bajpai J, Kagwade S, Chandrasekharan A, Dandekar S, Kanan S, Kembhavi Y, et al. Randomised controlled trial of scalp cooling for the prevention of chemotherapy induced alopecia. Breast 2020;49:187–93.